Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops

Clinical trial NCT00596791 · COMPLETED

Trial details

NCT number: NCT00596791
Sponsor: Santen Oy
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ocular Hypertension Open-Angle Glaucoma

Start date: 2008-01-01
Primary completion: 2008-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.